Triad doctor speaks on Tourette Syndrome
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Hinge Health to announce second quarter 2025 financial results on August 5, 2025
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarterly period ended June 30, 2025, after the close of the market on Tuesday, August 5, 2025. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relations website at A replay of the webcast will be available on the same website shortly after its completion. About Hinge Health Hinge Health is focused on scaling and automating the delivery of health care, starting with musculoskeletal conditions. Leveraging an AI-powered care model, a wearable device, and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that helps people move beyond pain, improving member outcomes and experiences and reducing costs for clients. The company is headquartered in San Francisco, California.
Boston Globe
2 hours ago
- Boston Globe
Civil complaint filed against Northampton pizza shop where woman with dairy allergy ate before death
She ordered a 'Sticky Ribs' appetizer and, for her main course, a 'Braised Short Rib & Grilled Red Onion Pizza,' which she requested be prepared with 'vegan/lactose free mozzarella,' the complaint said. Advertisement Soon after consuming the food, the complaint said, Hedin began 'experiencing symptoms of an allergic reaction' and 'suffered an anaphylactic reaction, resulting in a global hypoxic-ischemic brain injury.' Hedin died five days later, and since her death, 'the pizza has been stored in a freezer maintained by the Northampton Police Department labeled as 'Hedin's Food from HighBrow,'' the complaint said. Authorities have indicated they'll only release the pizza to be tested for dairy 'by agreement of the parties or by ... court order.' The parties have clashed over testing logistics, so Eric Hedin last month filed his civil 'complaint for discovery,' seeking a judge's order 'permitting Plaintiff to obtain evidence from the Northampton Police Department and to conduct testing of the pizza in accordance with the most recent protocol provided to Defendant.' Advertisement The restaurant on Tuesday referred questions to its lawyer, who didn't immediately respond to a request seeking comment. According to Eric Hedin's civil complaint, in December 2024, his lawyers proposed 'using Trelfa Labs, Inc. in Massachusetts, the only in-state facility equipped to conduct [the necessary] testing.' The following month, the complaint said, lawyers for the pizza shop responded, 'requesting a different, more complex quantitative test,' but 'no lab in Massachusetts performs these quantitative tests.' The complaint said Eric Hedin's team in February proposed a different lab for the testing, at the University of Nebraska headed by Dr. Joseph Baumert. But lawyers for the pizza shop have since 'insisted their expert be present' for the testing, something Baumert does not allow due to his lab's 'strict confidentiality policies,' the filing said. It said the lab can 'thoroughly photograph the pizza upon receipt and document each stage of testing.' To date, the complaint said, the business's counsel 'has not agreed to the testing and has offered no alternative solutions.' With the statute of limitations for filing suit approaching in a matter of months, the complaint said, 'Plaintiff is left with no alternative but to seek judicial intervention.' The complaint said Eric Hedin is seeking a judicial order allowing his lawyers to obtain the pizza from law enforcement to facilitate the testing at Baumert's lab. The civil complaint at this point is not seeking financial damages; just an order to get the testing moving. 'Plaintiff agrees to provide copies to Defendant of all materials received from Dr. Baumert relating to the testing,' the complaint said. Advertisement Kierstin Hedin was born in Florida and proved to be 'a child of the tropics, swimming by age 2, fascinated by lizards and fish, and the flocks of wild parrots that filled the trees in her backyard,' said She grew up in Keene and 'Klived life with a joyful heart and a spirit that was pure sunshine,' the obituary said. 'She came into this world a happy baby and grew to fill her family's home with laughter and fun.' The lawsuit was Travis Andersen can be reached at
Business Wire
2 hours ago
- Business Wire
Barbie® Introduces First-Ever Barbie Doll with Type 1 Diabetes to Expand Representation and Inspire More Children
EL SEGUNDO, Calif.--(BUSINESS WIRE)--Mattel, Inc. (NASDAQ: MAT) announced today that Barbie® is debuting the first Barbie doll with type 1 diabetes (T1D). This addition to the line enables more children to see themselves reflected in Barbie and encourages doll play that extends beyond a child's own lived experience, thereby fostering a greater sense of inclusion and empathy – all pillars of the Barbie brand's mission. 'Introducing a Barbie doll with type 1 diabetes marks an important step in our commitment to inclusivity and representation,' said Krista Berger, Senior Vice President of Barbie and Global Head of Dolls. 'Barbie helps shape children's early perceptions of the world, and by reflecting medical conditions like T1D, we ensure more kids can see themselves in the stories they imagine and the dolls they love.' To ensure the doll design truly captures the community, Barbie partnered with Breakthrough T1D (formerly JDRF), the leading global type 1 diabetes research and advocacy organization committed to accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications. T1D is a chronic autoimmune condition that causes the pancreas to make very little insulin or none at all, leading to dependence on insulin therapy and the risk of short and or long-term complications. Barbie worked closely with Breakthrough T1D to accurately reflect the medical equipment those with this condition may utilize and the doll's look, all the way down to the dress pattern: Continuous Glucose Monitor (CGM): The doll wears a CGM on her arm to help manage her type 1 diabetes. CGMs are small, wearable devices that continuously measure a person's blood-sugar levels. To keep her CGM in place, she uses heart-shaped medical tape – Barbie pink, of course – along with a phone that displays a CGM app to help track her blood sugar levels throughout the day. Insulin Pump: Barbie has an insulin pump, a small, wearable medical device that allows for automated insulin dosing as needed, attached to her waist. Blue Polka Dot Outfit: The doll wears a stylish polka dot top and matching skirt with ruffles. Both the color blue and circle print are nods to the global symbols that represent diabetes awareness. Purse: The doll comes with a pastel blue purse, perfect for Barbie to carry any essentials, such as type 1 diabetes supplies or snacks, when she's on the go. 'We were thrilled when Barbie approached us to collaborate on the development of the Barbie doll with type 1 diabetes,' said Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D. 'I have lived with T1D since I was 13, and my brother since he was 3, so this partnership is deeply personal – it means the world to be part of bringing greater visibility to a condition that affects so many families. It's an honor to work with a brand that shares our commitment to showing children that a life with type 1 diabetes can be full, vibrant, and empowering.' In continued partnership with Breakthrough T1D, Barbie donated dolls to the Breakthrough T1D 2025 Children's Congress. The biennial event, July 7-9, brings 170 children living with type 1 diabetes, ages 4-17, to Washington, DC, to meet face-to-face with members of Congress. The youth delegates travel to the nation's capital from all 50 states and Breakthrough T1D's international affiliates in the United Kingdom, Australia, Israel, the Netherlands, and Canada. Barbie also honored two global role models and type 1 diabetes advocates – Peloton Instructor Robin Arzón in the US and model Lila Moss in the UK – with their own one-of-a-kind Barbie dolls. Arzón unveiled the new Barbie doll with type 1 diabetes and her one-of-a-kind Barbie doll at Peloton Studios NY on July 8th. Attendees and Members of the type 1 diabetes community were delighted to experience this first-of-its-kind unveiling moment. 'After being diagnosed with type 1 diabetes a decade ago, I've found a lot of purpose in advocating for people with the condition and educating others about it because knowledge is power – especially for young minds,' said Arzón. 'It's an absolute honor to receive a Barbie doll as a part of the brand's efforts to grow awareness and representation surrounding type 1 diabetes, so that we can help show kids that all types of challenges give us all the more reason to push forward and achieve our dreams.' Lila Moss says, 'I am proud to use my platform to educate around type 1 diabetes and show that being different is cool. Receiving messages from people who see my patches and feel represented means everything to me. To be able to now see Barbie dolls with T1D, and to receive a Barbie doll that visibly looks like me even wearing her patches, is both surreal and special.' The Barbie Fashionistas line features more than 175 looks across various skin tones, eye colors, hair colors and textures, body types, disabilities, and fashion styles, including a Blind Barbie doll, a Barbie doll with Down Syndrome, and a Barbie doll with Hearing Aids, among others. In 2020, Barbie kicked off a multi-year study with researchers at Cardiff University on the short-term and long-term benefits of doll play. It has been found that doll play serves an incredible purpose during key developmental stages, as it may help set children on a course for success by fostering empathy and developing social skills needed to excel, all while imagining their futures on an equal playing field. The 2025 Barbie Fashionistas dolls commit to a minimum of 50% ISCC-Certified bio-circular plastic (Mass Balance Approach), with all boxes made from FSC-certified materials. By incorporating ISCC-certified plastic into these dolls, Barbie aims to reduce reliance on fossil-based materials in support of a more circular economy. The 2025 Barbie Fashionistas dolls, including the Barbie doll with Type 1 diabetes, are now available on Mattel Shop and at retailers nationwide. About Mattel Mattel is a leading global toy and family entertainment company and owner of one of the most iconic brand portfolios in the world. We engage consumers and fans through our franchise brands, including Barbie®, Hot Wheels®, Fisher-Price®, American Girl®, Thomas & Friends™, UNO®, Masters of the Universe®, Matchbox®, Monster High®, MEGA® and Polly Pocket®, as well as other popular properties that we own or license in partnership with global entertainment companies. Our offerings include toys, content, consumer products, digital and live experiences. Our products are sold in collaboration with the world's leading retail and ecommerce companies. Since its founding in 1945, Mattel is proud to be a trusted partner in empowering generations to explore the wonder of childhood and reach their full potential. Visit us at About Breakthrough T1D, Formerly JDRF As the leading global type 1 diabetes (T1D) research and advocacy organization, Breakthrough T1D (formerly JDRF) helps make everyday life with type 1 diabetes better while driving toward cures. We do this by investing in the most promising research, advocating for progress by working with government to address issues that impact the T1D community, and helping educate and empower individuals facing this condition. About Type 1 Diabetes (T1D) T1D is an autoimmune condition that causes the pancreas to make very little insulin or none at all. This leads to dependence on insulin therapy and the risk of short and long-term complications, which can include highs and lows in blood sugar; damage to the kidneys, eyes, nerves, and heart; and even death. Globally, it impacts nearly 9 million people. Many believe T1D is only diagnosed in childhood and adolescence, but diagnosis in adulthood is common and accounts for nearly 50% of all T1D diagnoses. The onset of T1D has nothing to do with diet or lifestyle. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. There is currently no cure for T1D. MAT-BARB
